Big Pharma Earnings - BMS to cut $1 Billion more

Tracy Staton at Fierce Biotech writes about the earnings reports that Big Pharma has announced over the last few days. The article is here.
While the news for the companies listed was generally upbeat....buried in the announcements are interesting tidbits such as the fact that Bristol-Myers Squibb is planning to cut another $1 Billion dollars...although the company did not provide any specifics.

These announcements further underscore the trend we have been seeing over the last few years.
Long Term Growth at the Big Pharma firms is a thing of the past. Big Pharma is at a loss to find products that can generate the revenue they need to support and grow their organizations. Big Pharma will not disappear. But going forward...if you are looking for stability and career growth...you are better off at a small or mid-size firms.

I expand on this discussion in a later post.